All changes for the tissue nervous system (640)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA1
abhydrolase domain containing 14A
Molecular
brain
Human
ABHD14A
3.0% Decrease Gene Expression Level
DAA2
abl-interactor 2
Molecular
brain
Human
ABI2
18.0% Decrease Gene Expression Level
DAA723
Accumulation of extracellular neuritic plaques
Physiological
brain
Human
—
—
DAA722
Accumulation of neuromelanin in dopaminergic nigral neurons
Physiological
substantia nigra
Human
—
—
DAA3
actin, alpha 1, skeletal muscle
Molecular
brain
Human
ACTA1
16.0% Decrease Gene Expression Level
DAA4
actin, beta
Molecular
brain
Human
ACTB
4.0% Decrease Gene Expression Level
DAA5
actin-like 6A
Molecular
brain
Human
ACTL6A
21.0% Increase Gene Expression Level
DAA761
Activation threshold for long-term potentiation is increased
Psychological
brain
Human
—
—
DAA618
Acute rheumatic fever and chronic rheumatic heart diseases
Pathological
heart, skin, brain
Human
—
SeriesMorbidity
DAA12
adaptor-related protein complex 1, sigma 1 subunit
Molecular
brain
Human
AP1S1
12.0% Decrease Gene Expression Level
DAA1978
Age differences in classical conditioning of the eyelid response
Physiological
eyelid
Human
—
—
DAA6
AHNAK nucleoprotein
Molecular
brain
Human
AHNAK
13.0% Increase Gene Expression Level
DAA7
aldehyde dehydrogenase 9 family, member A1
Molecular
brain
Human
ALDH9A1
10.0% Increase Gene Expression Level
DAA2033
Alterations in structural proteins and cell membranes in the lenses
Physiological
lens
Human
—
—
DAA2041
Altered brain mitochondrial metabolism
Physiological
brain
Human
—
—
DAA2031
Altered concentration of sodium, potassium and calcium
Physiological
lens
Human
—
—
DAA748
Altered sleep parameters and patterns
Psychological
brain
Human
—
—
DAA615
Alzheimer's disease
Pathological
brain
Human
—
SeriesMorbidity
DAA8
angiomotin
Molecular
brain
Human
AMOT
10.0% Increase Gene Expression Level
DAA9
ankyrin 2, neuronal
Molecular
brain
Human
ANK2
20.0% Decrease Gene Expression Level
DAA11
annexin A4
Molecular
brain
Human
ANXA4
11.0% Increase Gene Expression Level
DAA22
antizyme inhibitor 1
Molecular
brain
Human
AZIN1
11.0% Decrease Gene Expression Level
DAA1223
APOE promoter methylation decrease
Molecular
prefrontal cortex
Human
APOE
—
DAA13
apolipoprotein D
Molecular
brain
Human
APOD
14.0% Increase Gene Expression Level
DAA14
arylsulfatase A
Molecular
brain
Human
ARSA
17.0% Increase Gene Expression Level
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA1 | abhydrolase domain containing 14A | Molecular | brain | Human | ABHD14A | 3.0% Decrease Gene Expression Level | |
DAA2 | abl-interactor 2 | Molecular | brain | Human | ABI2 | 18.0% Decrease Gene Expression Level | |
DAA723 | Accumulation of extracellular neuritic plaques | Physiological | brain | Human | — | — | |
DAA722 | Accumulation of neuromelanin in dopaminergic nigral neurons | Physiological | substantia nigra | Human | — | — | |
DAA3 | actin, alpha 1, skeletal muscle | Molecular | brain | Human | ACTA1 | 16.0% Decrease Gene Expression Level | |
DAA4 | actin, beta | Molecular | brain | Human | ACTB | 4.0% Decrease Gene Expression Level | |
DAA5 | actin-like 6A | Molecular | brain | Human | ACTL6A | 21.0% Increase Gene Expression Level | |
DAA761 | Activation threshold for long-term potentiation is increased | Psychological | brain | Human | — | — | |
DAA618 | Acute rheumatic fever and chronic rheumatic heart diseases | Pathological | heart, skin, brain | Human | — | SeriesMorbidity | |
DAA12 | adaptor-related protein complex 1, sigma 1 subunit | Molecular | brain | Human | AP1S1 | 12.0% Decrease Gene Expression Level | |
DAA1978 | Age differences in classical conditioning of the eyelid response | Physiological | eyelid | Human | — | — | |
DAA6 | AHNAK nucleoprotein | Molecular | brain | Human | AHNAK | 13.0% Increase Gene Expression Level | |
DAA7 | aldehyde dehydrogenase 9 family, member A1 | Molecular | brain | Human | ALDH9A1 | 10.0% Increase Gene Expression Level | |
DAA2033 | Alterations in structural proteins and cell membranes in the lenses | Physiological | lens | Human | — | — | |
DAA2041 | Altered brain mitochondrial metabolism | Physiological | brain | Human | — | — | |
DAA2031 | Altered concentration of sodium, potassium and calcium | Physiological | lens | Human | — | — | |
DAA748 | Altered sleep parameters and patterns | Psychological | brain | Human | — | — | |
DAA615 | Alzheimer's disease | Pathological | brain | Human | — | SeriesMorbidity | |
DAA8 | angiomotin | Molecular | brain | Human | AMOT | 10.0% Increase Gene Expression Level | |
DAA9 | ankyrin 2, neuronal | Molecular | brain | Human | ANK2 | 20.0% Decrease Gene Expression Level | |
DAA11 | annexin A4 | Molecular | brain | Human | ANXA4 | 11.0% Increase Gene Expression Level | |
DAA22 | antizyme inhibitor 1 | Molecular | brain | Human | AZIN1 | 11.0% Decrease Gene Expression Level | |
DAA1223 | APOE promoter methylation decrease | Molecular | prefrontal cortex | Human | APOE | — | |
DAA13 | apolipoprotein D | Molecular | brain | Human | APOD | 14.0% Increase Gene Expression Level | |
DAA14 | arylsulfatase A | Molecular | brain | Human | ARSA | 17.0% Increase Gene Expression Level |